Examples of Initiatives by the JPMA
Public Relations Activities to Promote the Development of New Antimicrobials (Industry-Academia-Government Collaboration)
Nikkei-FT Infectious Diseases Conference
The AMR Subcommittee was established in 2019 as a subcommittee of the Nikkei Asia-Africa Healthcare Innovation Consortium (AMIC)—a public-private partnership (P3) project planned and implemented throughout the year by volunteers from the Nikkei-FT Infectious Diseases Conference.With the aim of proposing effective industrial policies that lead to sustainable research and development of antimicrobial agents, this subcommittee is jointly organized by the Nikkei Inc. and AMR Alliance Japan (Secretariat: Japan Health Policy Institute), and engages in ongoing discussions with stakeholders from industry, academia, government, and civil society.As a member of AMR Alliance Japan, the JPMA participates in the activities of the AMR Subcommittee.
The 12th Nikkei-FT Infectious Diseases Conference
Initiatives of the AMED Antimicrobial Industry-Academia-Government Liaison Committee
This liaison committee was established within the Japan Agency for Medical Research and Development (AMED) in September 2018 with the aim of examining future strategic approaches in the field of infectious diseases and, through these efforts, further promoting collaboration among industry, academia, and government in this field.The JPMA participates in this liaison committee as a representative of relevant pharmaceutical companies to exchange views with AMED and related academic societies (the Japanese Society for Infectious Diseases and the Japanese Society for Chemotherapy) on medical needs in the field of infectious diseases and development trends among pharmaceutical companies.
Collaboration with AMR Alliance Japan
Amid growing domestic and international concern regarding AMR, the Japan Health Policy Institute—which has been convening expert meetings on AMR since 2016—has concluded, based on the discussions at these meetings, that it is necessary to establish an independent, multi-stakeholder platform for discussing AMR and to create a collaborative framework capable of influencing AMR policy.In November 2018, the Japan Health Policy Institute, in collaboration with eight domestic academic societies related to infectious diseases, established the multi-stakeholder “AMR Alliance Japan” with the aim of improving public health by promoting measures against AMR.
As a member of AMR Alliance Japan, the JPMA is contributing to the advancement of AMR policies and the concrete implementation of countermeasures.
Activities of the AMR Subcommittee of the Nikkei Asia-Africa Medical Innovation Consortium (AMIC)
The AMR Subcommittee was established in 2019 as a subcommittee of the Nikkei Asia-Africa Medical Innovation Consortium (AMIC), which is organized by volunteers from the Nikkei-FT Infectious Diseases Conference to plan and implement public-private partnership (P3) projects throughout the year.With the aim of proposing effective industrial policies that lead to sustainable research and development of antimicrobial agents, this subcommittee is jointly organized by The Nikkei and AMR Alliance Japan (Secretariat: Japan Healthcare Policy Institute), and holds ongoing discussions with stakeholders from industry, government, academia, and civil society.As a member of AMR Alliance Japan, the JPMA participates in the activities of the AMR Subcommittee.
Antimicrobial Resistance (AMR) Action Fund
The Antimicrobial Resistance (AMR) Action Fund was established in July 2020 by more than 20 major biopharmaceutical companies as a groundbreaking initiative aimed at commercializing and delivering two to four new antimicrobial agents to patients by 2030.This fund is an initiative of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA); as an IFPMA member organization, the JPMA contributed to the fund’s establishment and is actively engaged in advocacy efforts.
Media Forum
As part of its efforts to foster a broad public understanding of the various issues and countermeasures related to AMR, the JPMA holds media forums for members of the press.
Seminars
Seminar on the 2021 AMR Preparedness Index (June 14, 2023)
The Global Health Subcommittee of the JPMA’s International Affairs Committee has We held a seminar on the 2021 AMR Preparedness Index to coincide with the visit to Japan by Michel Hodin, CEO of the Global Coalition on Aging (GCOA).
The Global Coalition on Antimicrobial Resistance (GCOA) takes a keen interest in the issue of antimicrobial resistance (AMR). It has developed the AMR Preparedness Index to evaluate the status of AMR countermeasures in various countries and published the results of its first assessment in 2021.GCOA-AMR-Preparedness-Index
Given that the second evaluation is currently underway, CEO Hodin provided an introduction to this Index.
In Japan, where the AMR Action Plan 2023–2027 has been finalized, we believe such an index is important to promote the steady implementation of this plan.
Presentation materials from the event areHere.
Antimicrobial Resistance (AMR) Seminar: History and Current Status of Infectious Disease Control—Lessons from Semmelweis—Held (November 22, 2019)
The JPMA, in collaboration with the Japan Medical Association, the National Graduate School of Policy Studies, and the Japan Health Policy Institute, held a seminar addressing antimicrobial resistance (AMR) as an urgent social issue, covering the history and current status of infectious disease control as well as the realities of antimicrobial drug development.The seminar was organized with the aim of deepening understanding of AMR among the general public, healthcare professionals, government officials, and others.
Various Surveys
Survey Report on the Issue of Antimicrobial-Resistant Bacteria
In June 2025, we compiled a survey report on the issue of antimicrobial-resistant bacteria.
We present the survey results regarding the severity of the AMR problem and the importance of new antimicrobials, as well as recommendations for the introduction of pull-type incentives in Japan.
Survey Report on the Issue of Antimicrobial-Resistant Bacteria
We are also publishing summaries of the reports below.
Two Oncologists Discuss the Current Situation and Challenges
Survey on Consumer Perceptions of Medicines and the Pharmaceutical Industry
The JPMA conducts the “Survey on Public Awareness of Medicines and the Pharmaceutical Industry” to assess the public’s actual understanding and perception of prescription drugs and the pharmaceutical industry, with the aim of using the findings as a basis for the JPMA’s public relations activities.
According to the results of the 18th survey conducted in fiscal year 2024, the level of awareness regarding AMR was as follows: 9.3% “know about it,” 18.0% “have heard or seen something about it,” and 72.7% “have never heard or seen anything about it.”Regarding awareness of AMR as an issue, 20.1% said they “view it as a personal concern,” 37.4% said they “did not know about it but think it is an important issue,” 9.2% said they “do not feel it is a personal concern,” and 33.4% said they “are not sure.”
Survey on Awareness Regarding the Promotion of New Antimicrobial Drug Development to Combat Antimicrobial Resistance
You can view the results of our awareness survey on AMR and antimicrobial drug development. We will continue this survey over the next few years and incorporate the findings into our AMR advocacy efforts.
a survey of physicians’ perceptions
Survey on Public Perceptions at Insurance-Covered Pharmacies
November 2019 — Results of a Survey on AMR Awareness Among the General Public Who Watched the “STOP AMR” Awareness Video —
With the cooperation of Quall Pharmacy, the JPMA’s AMR awareness video, “Stop AMR,” was screened at Quall Pharmacy locations nationwide. We conducted a survey of viewers during AMR Awareness Month (November 1–30) to gauge their awareness of AMR andthe effectiveness of the video in raising awareness and promoting AMR countermeasures. Regarding AMR, approximately 60% of respondents stated they had “never heard of it” before, and more than half reported that watching the video deepened their understanding of AMR.The results of this survey were presented orally at the Joint Academic Conference of the 69th East Japan Regional Meeting of the Japanese Society of Infectious Diseases and the 67th Assembly of the East Japan Branch of the Japanese Society of Chemotherapy, held in October 2020.
Enlarge